↓ Skip to main content

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers…

Overview of attention for article published in BMC Cancer, March 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

peer_reviews
1 peer review site

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
63 Mendeley